ExodusPoint Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Sell |
21,542
-57,618
| -73% | -$273K | ﹤0.01% | 1286 |
|
|
2025
Q1 | $363K | Buy |
79,160
+47,654
| +151% | +$219K | ﹤0.01% | 1132 |
|
|
2024
Q4 | $151K | Sell |
31,506
-94,144
| -75% | -$451K | ﹤0.01% | 1269 |
|
|
2024
Q3 | $589K | Buy |
+125,650
| New | +$589K | ﹤0.01% | 1066 |
|
|
2023
Q4 | – | Sell |
-150,399
| Closed | -$650K | – | 2018 |
|
|
2023
Q3 | $650K | Buy |
150,399
+76,577
| +104% | +$331K | 0.01% | 1102 |
|
|
2023
Q2 | $486K | Buy |
+73,822
| New | +$486K | ﹤0.01% | 1281 |
|
|
2022
Q4 | – | Sell |
-10,099
| Closed | -$100K | – | 2106 |
|
|
2022
Q3 | $100K | Sell |
10,099
-128,077
| -93% | -$1.27M | ﹤0.01% | 1712 |
|
|
2022
Q2 | $1.51M | Buy |
138,176
+65,045
| +89% | +$709K | 0.02% | 867 |
|
|
2022
Q1 | $827K | Buy |
73,131
+28,316
| +63% | +$320K | 0.01% | 1206 |
|
|
2021
Q4 | $703K | Buy |
+44,815
| New | +$703K | 0.01% | 1208 |
|
|
2021
Q3 | – | Sell |
-17,034
| Closed | -$366K | – | 2596 |
|
|
2021
Q2 | $366K | Sell |
17,034
-37,368
| -69% | -$803K | ﹤0.01% | 1544 |
|
|
2021
Q1 | $817K | Buy |
54,402
+41,515
| +322% | +$623K | 0.01% | 996 |
|
|
2020
Q4 | $169K | Buy |
+12,887
| New | +$169K | ﹤0.01% | 1693 |
|
|
2020
Q1 | – | Sell |
-26,968
| Closed | -$443K | – | 1611 |
|
|
2019
Q4 | $443K | Buy |
+26,968
| New | +$443K | 0.01% | 876 |
|